ACADIA Pharmaceuticals Inc. (ACAD) Gained 5.2% or 1.14 To Price $23.07 On Friday


ACADIA Pharmaceuticals Inc. (ACAD) gained 5.2% or 1.14 to $23.07. It is approximately 1.30 million shares traded, which is 84.08% compare to the average total volume 1.55 million. The market cap of ACAD is $2.89 billion. The year to date change is 36.91%. The 52 week price range is from $12.77 to $32.53. Price of ACAD have changed -0.27% during last week. It have changed 6.15% over last month, 25.10% over last 3 months, 53.04% over last 6 months and -28.33% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ACAD is 19.69. It is -14.65% below current price. The 200-day Moving Averages for ACAD is 18.04. It is -21.80% below current price. The 52-week High is 32.53. It is 41.01% from the current price. The 52-week Low is 12.77. It is -44.65% from current price.

There are some statistics of ACAD. It is has market cap $2.89 billion. The share outstanding is 125.07 million. The average volume is 1.55 million. The percent of top 15 Institution holding is 152.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ACAD is -83.29%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ACAD is -73.55%.


Tags:

Share this post